Global Patent Index - EP 0755251 A1

EP 0755251 A1 19970129 - LOW DOSAGE RANITIDINE COMPOSITIONS FOR THE TREATMENT OF MINOR GASTROINTESTINAL DISORDERS ASSOCIATED WITH EXCESS ACID SECRETION

Title (en)

LOW DOSAGE RANITIDINE COMPOSITIONS FOR THE TREATMENT OF MINOR GASTROINTESTINAL DISORDERS ASSOCIATED WITH EXCESS ACID SECRETION

Title (de)

WIEDRIGDOSIERTE RANITIDINZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON LEICHTEN GASTROINTESTINALEN BESCHWERDEN, DIE MIT ERHÖHTER SÄURESEKRETION VERBUNDEN SIND

Title (fr)

COMPOSITIONS FAIBLEMENT DOSEES EN RANITIDINE DESTINEES AU TRAITEMENT DE TROUBLES GASTRO-INTESTINAUX MINEURS LIES A UN EXCES DE SECRETION ACIDE

Publication

EP 0755251 A1 19970129 (EN)

Application

EP 95914346 A 19950410

Priority

  • EP 9501271 W 19950410
  • GB 9407235 A 19940412

Abstract (en)

[origin: WO9527486A1] The present invention relates to low dosage formulations containing the histamine H2-receptor antagonist ranitidine and their use in the treatment of gastric disorders such as episodic heartburn.

IPC 1-7

A61K 31/34

IPC 8 full level

A61K 31/34 (2006.01); A61K 31/341 (2006.01); A61P 1/04 (2006.01); C07D 307/52 (2006.01)

CPC (source: EP KR)

A61K 31/34 (2013.01 - EP KR); A61P 1/04 (2017.12 - EP)

Citation (search report)

See references of WO 9527486A1

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9527486 A1 19951019; AU 2138095 A 19951030; AU 690664 B2 19980430; BR 9507312 A 19971007; CA 2187651 A1 19951019; CN 1146150 A 19970326; EP 0755251 A1 19970129; GB 9407235 D0 19940608; JP H10502331 A 19980303; KR 970702034 A 19970513; MX 9604553 A 19971129; NZ 283354 A 19980826; ZA 952931 B 19960105

DOCDB simple family (application)

EP 9501271 W 19950410; AU 2138095 A 19950410; BR 9507312 A 19950410; CA 2187651 A 19950410; CN 95192537 A 19950410; EP 95914346 A 19950410; GB 9407235 A 19940412; JP 52606895 A 19950410; KR 19960705716 A 19961011; MX 9604553 A 19950410; NZ 28335495 A 19950410; ZA 952931 A 19950410